InsidersTradesSigma
Track the 삼양바이오팜 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 삼양바이오팜 has logged 1 insider filings. Market capitalisation: €282.6bn. The latest transaction was disclosed on 4 March 2026 (Other). Among the most active insiders: 김윤. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Samyang Biopharm es una empresa del sector de la salud y farmacéutico, cotizada en el mercado XKRX. Se especializa en el desarrollo de productos farmacéuticos innovadores.